ACTION FOR A-T — grant history

Registered charity 1145303 · filings on the Charity Commission register · its own accounts analysis · funder finder · deadlines · watch this funder · check a grantee list

Latest income
£905k
Grants listed (FY2025)
13
Listed grants total
£1.7m
Accounts grants total
£116k

Write-backs & cancellations (all years shown): 8 entries, −£124k. These are listed separately below and are not netted off the grant totals or counted as grants.

listed grants do not fully reconcile with the accounts total — list may be partialextracted from its FY2025 accounts

What changed: FY2024 → FY2025

Grantees that appear, disappear or move by 50%+ between the two most recent filings that have counted grants (unverified reads are left out, so a filing whose grants are all unverified is skipped). A grantee “dropped” may simply have received a multi-year grant earlier.

ChangeGranteeFY2024FY2025
newUniversities of Birmingham, UK & Hamburg, Germany—£250k
newUniversity of North Carolina, USA—£249k
newQIMR Berghofer Medical Research Institute, Queensland, Australia—£58k
newUniversity of Cambridge, UK—£20k
not listedUniversity of Hamburg and University of Birmingham£250k—
not listedUniversity of North Carolina at Chapel Hill, USA£249k—
not listedUniversity College London (UCL), UK£25k—
not listedUniversity of Nottingham£20k—
not listedUniversity of Cambridge£20k—

Grants made, per its accounts filings

Download this grant history as CSV (open data, provenance and licence noted in the file).

RecipientYearAmountPurpose
Leiden University Medical Centre, NetherlandsFY2025£250kFunctional impact of Nicotinamide Riboside on the immune system of patients with A-T
University of Kent, UKFY2025£250kInvestigating the role of mutant triple T chaperone in ATM assembly in A-T
Universities of Birmingham, UK & Hamburg, GermanyFY2025£250kDevelopment of suppressor tRNA-based therapeutics
University of Birmingham, UKFY2025£249kIdentifying existing drugs to repurpose for treating A-T
University of North Carolina, USAFY2025£249kDevelopment of a gene therapy approach to treat A-T
University of Nottingham, UKFY2025£247kBiomarkers for babies and young children with A-T
QIMR Berghofer Medical Research Institute, Queensland, AustraliaFY2025£58kDose response and mechanistic profiling of two candidate neuroactive drugs in A-T cerebellar organoids
University of Nottingham, UKFY2025£20kExploring the use of assistive robots, smart sensing & digital twin models for monitoring and support of Ataxia in non-clinical environments
University of Cambridge, UKFY2025£20kImproving diagnosis and treatment of cancer in A-T patients through whole genome sequencing
University of Nottingham, UKFY2025£20kDeveloping a Safer Immune‑Based Treatment for Blood Cancers in Children and Adults with A‑T
University of Nottingham, UKFY2025£20kA prospective pilot study to compare lung CT and MRI in Ataxia Telangiectasia
University of Nottingham, UKFY2025£19kKicking Kinases into action: A novel drug screening assay for A-T
University of Nottingham, UKFY2025£18kImproving future treatments for Ataxia-Telangiectasia through better delivery of RNA-based therapies
Leiden University Medical Centre, NetherlandsFY2024£250kFunctional impact of Nicotinamide Riboside on the immune system of patients with A-T
University of Kent, UKFY2024£250kInvestigating the role of mutant Triple T chaperone in ATM assembly in Ataxia Telangiectasia
University of Hamburg and University of BirminghamFY2024£250kDevelopment of suppressor tRNA-based therapeutics
University of Birmingham, UKFY2024£249kIdentifying existing drugs to repurpose for treating Ataxia-Telangiectasia
University of North Carolina at Chapel Hill, USAFY2024£249kDevelopment of a Gene Therapy approach to treat A-T
University of Nottingham, UKFY2024£247kBiomarkers for Babies and Young Children with Ataxia Telangiectasia (BOBCAT)
University College London (UCL), UKFY2024£25kExploring Omaveloxolone efficacy in Ataxia-telangiectasia
University of NottinghamFY2024£20kExploring the Use of Assistive Robots, Smart Sensing and Digital Twin Models for Monitoring and Support of Ataxia in Non-Clinical Environments
University of CambridgeFY2024£20kImproving diagnosis and treatment of cancer in Ataxia-Telangiectasia patients through whole genome sequencing
University of NottinghamFY2024£19kKicking Kinases into Action: A novel drug screening assay for A-T
Oslo University Hospital, NorwayFY2023£25kPreclinical Assessment of Intrathecal rAAV9-Mediated miATM Therapy for Ataxia Telangiectasia in Mouse Models
Institute for Bioengineering of Catalonia, SpainFY2023£25kModelling Ataxia Telangiectasia pathogenesis and therapeutics using human pluripotent stem cells and genetic engineering
University of Nottingham, UKFY2023£20kSTIM A-T Pilot Study
University of Nottingham, UKFY2023£19kVirtual Reality in Ataxia-Telangiectasia
University of Nottingham, UKFY2023£863Sandpit Event
University of Cambridge, UKFY2022£250kTrial REadiness in Ataxia Telangiectasia (TREAT-AT)
QIMR Berghofer Medical Research Institute, Queensland, AustraliaFY2022£152kDigital drug prediction informed by genetic analysis of stem cell-derived mini-brains from A-T patients
University of Nottingham, UKFY2022£147kBrain-penetrating ATM gene therapy
IFOM – The FIRC Institute of Molecular Oncology, Milan, ItalyFY2022£126kUnderstanding and correcting glucose metabolism defects in Ataxia-Telangiectasia
Bambino Gesù Children’s Hospital, ItalyFY2022£91kStudy of natural killer cells in A-T pathogenesis and their therapeutic implications
Duke University, USAFY2021£250kA new function for ATM and a new theory for the clinical abnormalities in A-T
University of Rochester, USAFY2021£247kRecurrent pulmonary infections and their impact on neurological decline in A-T
University of Texas, USAFY2021£23kA-T cerebellar neurodegeneration and inositol phosphate signalling

Write-backs & cancellations

8 entries totalling −£124k in this funder’s accounts are negative amounts, such as the write-back of an accrued grant or a cancelled grant. They are shown here on their own and are not netted off the grants total or counted as grants above. They are in the CSV with amount_note “write_back”.

RecipientYearAmountPurpose
Nottingham University Hospital, UKFY2023−£22kNatural History of A-T (underspends refunded)
University of Birmingham, UKFY2023−£15kAssessment of the frequencies and types of cancers occurring in A-T patients (underspends refunded)
University of Birmingham, UKFY2023−£29Deciphering the molecular mechanism linking Ataxia-Telangiectasia and Ataxia-Telangiectasia-Like Disorder (underspends refunded)
Nottingham University Hospital, UKFY2022−£22k(Research project underspends refunded) Natural History of A-T
University of Birmingham, UKFY2021−£33k(Research project underspends refunded) Identifying new therapies for blood cancers in patients with A-T
Oxford University, UKFY2021−£16k(Research project underspends refunded) - The use of patient stem cell-derived mini-brains to study A-T
Imagin Institute Paris, FranceFY2021−£7k(Research project underspends refunded) - Does irregular repair of DNA damage in Neurons and Lymphocytes cause cellular degeneration in A-T patients?
Nottingham University Hospital, UKFY2021−£7k(Research project underspends refunded) longitudinal brain changes in childhood A-T

About this data

This grant list is extracted by automated reading of the grant-maker’s own accounts PDFs as filed with the Charity Commission, and cross-checked against the accounts’ stated grant totals (listed sum 1670384 vs reference 116441 (1334.5% diff; ref=stated)). Recipients are linked to register entries only on an exact charity-number or unambiguous exact-name match. If you represent this funder or a recipient and want a correction, email [email protected].